Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05370859 · ClinicalTrials.gov registry record
mMe: Motivational Monitoring to Enhance Smoking Cessation Among Cancer Patients
A clinical trial, sponsored by University of Virginia.
- Completed
- Registry status
- 25
- Enrollment target
NCT05370859: Completed study, sponsored by University of Virginia.
NCT05370859 is a clinical trial that has completed, run by University of Virginia. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05370859 has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The objectives of this study are to pilot test a protocol of weekly assessments of motivation to quit and other relevant constructs combined with information about how to enroll in cessation programs, which will allow initial quantification of motivation to quit during cancer treatment and develop hypotheses about the impact of motivation on the decision to enroll in services.
Primary Outcome
Assessed using administrative records
Interventions
- OTHER There is no intervention for this study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-07-18 |
| Est. Completion | 2024-02-13 |
What the finished NCT05370859 record still lists
NCT05370859 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which There is no intervention for this study is the first listed.
NCT05370859 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05370859 about?
NCT05370859 is a clinical study titled "mMe: Motivational Monitoring to Enhance Smoking Cessation Among Cancer Patients". The objectives of this study are to pilot test a protocol of weekly assessments of motivation to quit and other relevant constructs combined with information about how to enroll in cessation programs, which will allow initial quantification of motivation to quit during cancer treatment and develop h...
What is the current status of trial NCT05370859?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2022-07-18. Estimated completion is 2024-02-13.
What interventions are being tested in trial NCT05370859?
The interventions under investigation include: There is no intervention for this study (OTHER).
Who is sponsoring clinical trial NCT05370859?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI